Zhenhai Gao

Zhenhai Gao has extensive work experience in the pharmaceutical and biotechnology industries. From 2017 to present, they have served as Co-Founder, President & CEO, Co-Founder & President, and Co-Founder and CSO at NiKang Therapeutics Inc. From 2014 to 2017, they were Senior Director, Cancer Biology/Pharmacology at Incyte. From 2007 to 2014, they were Associate Director at Novartis Institutes for Biomedical Research. From 2005 to 2007, they were Senior Scientist at Novartis Institutes for BioMedical Research. From 2001 to 2005, they were Principal Scientist and Scientist II at Chiron Corporation (now Novartis Institutes for Biomedical Research). From 1999 to 2001, they were Scientist II at CV Therapeutics (now Gilead Sciences).

Zhenhai Gao obtained a Ph.D. in Molecular Pharmacology from the University of Virginia School of Medicine and a BS in Biology from Nankai University.